Introduction
Materials and methods
Results
Risk < 15% | Risk 15–30% | Risk > 30% | Total | |
---|---|---|---|---|
Patients | 138 | 96 | 39 | 273 |
Female/male | 81/57 | 59/46 | 23/16 | 159/114 |
Agea | 53 (18–75) | 66 (18–87) | 74 (45–87) | 61 (18–87) |
BMI (kg/m2)a | 26.7 (17–45) | 27.2 (18–40) | 27.0 (18–38) | 27.0 (17–45) |
CCIb | 2 (0–10) | 3 (0–11) | 5 (0–13) | 3 (0–13) |
Preexisting conditionsb | 1 (0–6) | 2 (0–5) | 4 (0–7) | 2 (0–7) |
SIIb | 3 (1–18) | 8 (1–31) | 10 (1–30) | 8 (1–31) |
ASA I | 21.7% (30) | 3.1% (3) | – | 12.1% (33) |
ASA II | 64.5% (89) | 55.2% (53) | 25.6% (10) | 55.7% (152) |
ASA III | 13.1% (18) | 38.6% (37) | 66.7% (26) | 29.7% (81) |
ASA IV | 0.7% (1) | 3.1% (3) | 7.7% (3) | 2.5% (7) |
Degenerative | 90.6% (125) | 84.4% (81) | 51.3% (20) | 82.8% (226) |
Trauma | – | 1.0% (1) | 23.1% (9) | 3.7% (10) |
Neoplasm | 9.4% (13) | 10.4% (10) | 7.7% (3) | 9.5% (26) |
Infection | – | 4.2% (4) | 17.9% (79) | 4.0% (11) |
Cervical | 14.5% (20) | 9.4% (9) | 12.8% (5) | 12.4% (34) |
Thoracic | 6.5% (9) | 8.3% (8) | 18.0% (7) | 8.8% (24) |
Lumbosacral | 79.0% (109) | 83.3% (79) | 69.2% (27) | 78.8% (215) |
Anterior | 11.6% (16) | 1.0% (1) | – | 6.2% (17) |
Posterior | 87.7% (121) | 95.9% (92) | 100% (39) | 92.3% (252) |
Combined | 0.7% (1) | 3.1% (3) | – | 1.5% (4) |
Major medical complications | Overall medical complications | Risk group < 15% | Risk group 15–30% | Risk group > 30% | |
---|---|---|---|---|---|
Median predicted risk (range) | 3.8% (0.5–63.8%) | 14.7% (3.3–89.2%) | 10.8% (2.7–14.9%) | 18.9% (15.1–29.7%) | 41.1% (30.4–89.2%) |
Actual rate of occurred medical complications (95% CI) | 3.3% (n = 9) (95% CI 1.7–6.1) | 16.1% (n = 44) (95% CI 12.2–20.9) | 8.7% (n = 12) (95% CI 5.0–14.6) | 17.7% (n = 17) (95% CI 11.4–26.5) | 38.5% (n = 15) (95% CI 24.9–54.1) |
p value | 0.515 | 0.693 | 0.418 | 0.767 | 0.731 |
Gender | Age | Diagnosis | Level | BMI | CCI | Preexisting conditions | SII | ASA | Risk major complications (%) | Risk overall complications (%) |
---|---|---|---|---|---|---|---|---|---|---|
F | 73 | N | C | 23.5 | 10 | 3 | 12 | 4 | 5.5 | 22.1 |
F | 74 | D | L | 23.9 | 6 | 3 | 12 | 3 | 5.7 | 41.2 |
M | 45 | D | L | 37.1 | 0 | 0 | 30 | 2 | 7.1 | 32.3 |
M | 60 | D | L | 30.1 | 3 | 2 | 14 | 2 | 7.7 | 21.8 |
F | 75 | D | L | 35.5 | 3 | 1 | 12 | 3 | 9.1 | 23.0 |
M | 82 | N | L | 29.4 | 10 | 1 | 12 | 3 | 11.2 | 26.3 |
M | 74 | D | T | 28.9 | 3 | 2 | 28 | 3 | 19.7 | 42.2 |
F | 77 | I | T | 24.5 | 4 | 2 | 10 | 3 | 28.6 | 48.6 |
M | 75 | T | T | 36.7 | 5 | 6 | 15 | 3 | 63.8 | 89.2 |
Major medical complications | All medical complications | |
---|---|---|
AUC (95% CI) | 0.71 (95% CI 0.63–0.80) | 0.85 (95% CI 0.773–0.929) |
p value | < 0.001 | < 0.001 |